Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Tapan Daftari

Orthopaedic Surgery of the Spine Austell, GA Medical Doctor

NPI 1649267329 CMS profile 165644

2041 Mesa Valley Way, Suite 100, Austell, GA 30106

Open in the dashboard

General payments

$759,097

552 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,150 paid to institutions, not to them · program year 2021

Through program year 2025, Tapan Daftari of Austell, GA is reported in the CMS Open Payments database as having received $759,097 across 552 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $1,150 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $109,670 66
2024 General $115,556 78
2023 General $77,605 69
2022 General $106,198 74
2021 General $107,306 95
2020 General $109,644 71
2019 General $133,118 99

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Tapan Daftari
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Tapan Daftari were reported at $109,670. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Tapan Daftari Orthopaedic Surgery of the Spine median Middle half National median
2019 $133,118 $2,106 $337–$18,608 $163
2020 $109,644 $1,213 $156–$15,082 $114
2021 $107,306 $1,834 $271–$15,617 $132
2022 $106,198 $2,015 $320–$17,036 $149
2023 $77,605 $1,925 $336–$14,599 $160
2024 $115,556 $2,110 $341–$12,483 $164
2025 $109,670 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $468,334 153 payments
  2. Medacta USA, Inc. $222,155 159 payments
  3. MiRus, LLC $19,942 7 payments
  4. GS Solutions, Inc. $8,000 1 payment
  5. Seaspine Orthopedics Corporation $6,273 35 payments
  6. Aesculap Implant Systems, LLC $5,656 15 payments
  7. Alphatec Spine, Inc $3,725 5 payments
  8. Spineology Inc. $3,724 29 payments
  9. Life Spine, Inc. $3,597 10 payments
  10. Camber Spine Technologies $3,582 19 payments
  11. Other $14,108 119 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $342,012 43 payments
  2. Consulting Fee $203,225 51 payments
  3. Travel and Lodging $110,091 152 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $78,050 15 payments
  5. Food and Beverage $21,615 288 payments
  6. Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program $4,000 1 payment
  7. Education $63 1 payment
  8. Gift $42 1 payment
Products named General payments · program years 2019–2025
  1. PROVIDENCE $96,866 6 payments
  2. COALITION AGX / AGX RP $75,541 10 payments
  3. COALITION AGX Spine/Spine Surgery $50,770 5 payments
  4. MYSPINE Spine $41,278 59 payments
  5. COALITION AGX Spine/Joint $40,215 4 payments
  6. COALITION AGX Spine $39,584 4 payments
  7. MySpine Spine $39,055 25 payments
  8. MySpine Orthopedics/Orthopedic Surgery $26,652 18 payments
  9. EUROPA Pedicle Screw System $19,942 7 payments
  10. Mecta-C Cervical Cages $19,741 4 payments
  11. Other $245,076 409 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 19 drugs

Part D claims

867

Median for Orthopedic Surgery: 203

Drug cost

$7,713

Median for Orthopedic Surgery: $1,433

Branded share of claims

14.5%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 219 $2,090
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 59 $868
Cyclobenzaprine Hcl Generic 67 $800
Celecoxib Generic 52 $655
Methocarbamol Generic 61 $611
Enoxaparin Sodium Generic 12 $577
Tramadol Hcl Generic 76 $345
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 31 $304
Diclofenac Sodium Generic 20 $242
Pregabalin Generic 22 $231

The 10 drugs with the highest cost, of 19 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 61 billing codes

Paid by Medicare

$120,810

Of which drugs: $108

Medicare patients

198

Average age 72

Services billed

1,722

109 women, 89 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 33%
Depression 28%
Diabetes 26%
Osteoporosis 20%
Chronic kidney disease 19%
Cancer 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, methylprednisolone acetate, 1 mg J1010 Office 11 960 $93

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Tymlos
  • Radius Health, Inc. $31
$31 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

552 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record